BB vs CMMB · P/E 117, rev $549.1M vs $22.2M cap
BlackBerry Ltd (BB) versus Chemomab Therapeutics Ltd DRC (CMMB) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Chemomab Therapeutics Ltd DRC (CMMB) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
CMMB does not have a complete income-statement cache yet.
BB currently screens at market cap $6.14B and trailing P/E 116.5. CMMB currently screens at market cap $22.2M.
Not investment advice. Open the BB and CMMB stock pages for the full models.
Not investment advice.